Literature DB >> 20417794

Repair of atrial septal defect with Eisenmenger syndrome after long-term sildenafil therapy.

Young-Hwue Kim1, Jeong Jin Yu, Tae-Jin Yun, Yonghee Lee, Yong Beom Kim, Hyung Soon Choi, Won Kyoung Jhang, Hong Ju Shin, Jeong-Jun Park, Dong-Man Seo, Jae-Kon Ko, In-Sook Park.   

Abstract

We report a woman with atrial septal defect and severe pulmonary hypertension with 25.0 Wood unit.m(2) of indexed total pulmonary vascular resistance. She underwent successful corrective repair of atrial septal defect after 2 years of treatment with sildenafil, and has been monitored for 4 years after repair. This case supports a "treat and repair" approach using advanced pulmonary vasodilator therapy in selected patients with inoperable severe pulmonary hypertension associated with atrial septal defect. Copyright (c) 2010 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20417794     DOI： 10.1016/j.athoracsur.2009.10.027

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN： 0003-4975            Impact factor:   4.330


  9 in total

Review 1.  "Treat and repair" strategy for shunt lesions: a critical review.

Authors:  Balaji Arvind; Jay Relan; Shyam S Kothari
Journal:  Pulm Circ       Date:  2020-04-09       Impact factor: 3.017

2.  Device closure of a large atrial septal defect in a patient with severe pulmonary arterial hypertension after 1 year use of an oral endothelin receptor antagonist.

Authors:  In Hyun Jung; Sang Yun Lee; Sook Jin Lee; Joo Young Lee; Nam Jin Park; Dea Sung Ahn; Jae Hoon Jung; Dong Hee Shin; Dal Soo Lim
Journal:  J Cardiovasc Ultrasound       Date:  2013-09-30

Review 3.  Surgical closure of atrial septal defects.

Authors:  Matthew Liava'a; David Kalfa
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

Review 4.  Atrial septal defect and exercise capacity: value of cardio-pulmonary exercise test in assessment and follow-up.

Authors:  Pascal Amedro; Sophie Guillaumont; Charlene Bredy; Stefan Matecki; Arthur Gavotto
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

5.  Transient use of oral bosentan can be an additional option to reduce pulmonary arterial hypertension in a patient with severe pulmonary arterial hypertension associated with atrial septal defect.

Authors:  Yong Kyu Park; Jae-Hyeong Park; Jae Hyeon Yu; Jun Hyung Kim; Jae-Hwan Lee; Si Wan Choi; Jin-Ok Jeong; In-Whan Seong
Journal:  J Cardiovasc Ultrasound       Date:  2011-09-30

6.  Secundum atrial septal defect with Eisenmenger syndrome: A scarcely reported disease in Nigeria.

Authors:  Nnamdi I Nwosu; Emeka Omejua; Nneka Udora; Ezinne Nwosu
Journal:  Niger Med J       Date:  2017 Mar-Apr

7.  Long-Term Survival of Adult Patients With Atrial Septal Defect With Regards to Defect Closure and Pulmonary Hypertension.

Authors:  Jana Rubáčková Popelová; Markéta Tomková; Jakub Tomek; Renata Živná
Journal:  Front Cardiovasc Med       Date:  2022-04-28

8.  Subsequent shunt closure after targeted medical therapy can be an effective strategy for secundum atrial septal defect with severe pulmonary arterial hypertension: two case reports : strategy for ASD with severe PAH.

Authors:  Yu Taniguchi; Noriaki Emoto; Kazuya Miyagawa; Kazuhiko Nakayama; Hiroto Kinutani; Hidekazu Tanaka; Toshiro Shinke; Kenji Okada; Yutaka Okita; Ken-ich Hirata
Journal:  Heart Vessels       Date:  2013-04-18       Impact factor: 2.037

9.  Pushing the envelope: a treat and repair strategy for patients with advanced pulmonary hypertension associated with congenital heart disease.

Authors:  Rebecca Johnson Kameny; Elizabeth Colglazier; Hythem Nawaytou; Phillip Moore; V Mohan Reddy; David Teitel; Jeffrey R Fineman
Journal:  Pulm Circ       Date:  2017-09-01       Impact factor: 3.017
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.